Literature DB >> 9789834

Molecular interactions of acetylcholinesterase with senile plaques.

N C Inestrosa1, R Alarcón.   

Abstract

Acetylcholinesterase (AChE) present in Alzheimer plaques is resistant to low pH, anti-ChE inhibitors and high substrate concentrations in comparison with the free enzyme. Kinetic and pharmacological studies of AChE-amyloid complexes indicate that steric hindrance by the amyloid over the gorge and the peripheral site of AChE is responsible for these effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9789834     DOI: 10.1016/S0928-4257(99)80002-3

Source DB:  PubMed          Journal:  J Physiol Paris        ISSN: 0928-4257


  15 in total

Review 1.  Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.

Authors:  Reinhard Schliebs
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

2.  Targeting acetylcholinesterase to membrane rafts: a function mediated by the proline-rich membrane anchor (PRiMA) in neurons.

Authors:  Heidi Q Xie; Dong Liang; K Wing Leung; Vicky P Chen; Kevin Y Zhu; Wallace K B Chan; Roy C Y Choi; Jean Massoulié; Karl W K Tsim
Journal:  J Biol Chem       Date:  2010-02-10       Impact factor: 5.157

Review 3.  The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.

Authors:  R Schliebs; T Arendt
Journal:  J Neural Transm (Vienna)       Date:  2006-10-13       Impact factor: 3.575

Review 4.  Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.

Authors:  David G Wilkinson; Paul T Francis; Elias Schwam; Jennifer Payne-Parrish
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 5.  Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase.

Authors:  Hai Yan Zhang; Han Yan; Xi Can Tang
Journal:  Cell Mol Neurobiol       Date:  2007-07-27       Impact factor: 5.046

6.  Three N-Glycosylation Sites of Human Acetylcholinesterase Shares Similar Glycan Composition.

Authors:  Miranda L Xu; Wilson K W Luk; Kei M Lau; Cathy W C Bi; Anthony W M Cheng; Amy G W Gong; Huangquan Lin; Karl W K Tsim
Journal:  J Mol Neurosci       Date:  2015-08-01       Impact factor: 3.444

Review 7.  Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease.

Authors:  Karl Herholz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

8.  Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying on.

Authors:  George T Grossberg
Journal:  Curr Ther Res Clin Exp       Date:  2003-04

Review 9.  Inclusion body myositis: a view from the Caenorhabditis elegans muscle.

Authors:  Daniela L Rebolledo; Alicia N Minniti; Paula M Grez; Ricardo Fadic; Rebecca Kohn; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.590

10.  Cholinesterase inhibitory activity of tinosporide and 8-hydroxytinosporide isolated from Tinospora cordifolia: In vitro and in silico studies targeting management of Alzheimer's disease.

Authors:  Mohiminul Adib; Rashedul Islam; Monira Ahsan; Arifur Rahman; Mahmud Hossain; Md Mustafizur Rahman; Sultan M Alshehri; Mohsin Kazi; Md Abdul Mazid
Journal:  Saudi J Biol Sci       Date:  2021-03-30       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.